Skip to main content
Clinical Trials/NCT05843890
NCT05843890
Recruiting
Not Applicable

Tailored Pain Guide (TPG) Study

University of Michigan1 site in 1 country550 target enrollmentAugust 18, 2023

Overview

Phase
Not Applicable
Intervention
Structured and tailored PainGuide
Conditions
Chronic Lower Back Pain
Sponsor
University of Michigan
Enrollment
550
Locations
1
Primary Endpoint
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference score
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

This research is studying whether changing an individual's behaviors may have an impact as a treatment or outcome for chronic low back pain. This research will try to understand how much an electronic, self-management website like PainGuide can help participants.

The study hypothesizes that tailored digital interventions (plus using PainGuide) will demonstrate greater improvement in pain interference.

Detailed Description

There was an amendment approved by the University of Michigan Medical School Institutional Review Board (AME00158411). This amendment included the following: increased enrollment numbers, updated recruitment procedures including the Non-Pharma Program (NPP) Sub-Study, as well as changes in time frames.

Registry
clinicaltrials.gov
Start Date
August 18, 2023
End Date
February 1, 2028
Last Updated
last month
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Daniel Clauw, MD

Professor of Anesthesiology

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • Chronic Lower Back pain (cLBP) defined by the National Institutes of Health (NIH) Task Force Report on Research Standards for Chronic Low Back Pain, (i.e., low back pain present at least six months, and present more than half of those days.)
  • Individuals must have a score of greater or equal to (≥) 60 on PROMIS Pain Interference.
  • Non-Pharma Sub-study:
  • Must be referred and currently on the waitlist for the NPP at the Back \& Pain Center (BPC)

Exclusion Criteria

  • Current cancer related pain
  • Diagnosis of autoimmune disease
  • Unable to speak, write or read English
  • Visual or hearing difficulties
  • Pregnancy or breastfeeding
  • Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators.

Arms & Interventions

Structured and tailored PainGuide

Intervention: Structured and tailored PainGuide

Standard PainGuide

Intervention: Standard PainGuide

Outcomes

Primary Outcomes

Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference score

Time Frame: Baseline, Week 24

The PROMIS Pain Interference consists of 4-items that assess the degree to which pain interferes with various aspects of life. Items are scored on a 1 ("Not at all") to 5 ("Very much") scale with a range of 4 - 20. Higher scores indicate greater pain interference

Secondary Outcomes

  • Change in pain intensity based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0(Baseline, Week 24 (initial group), Week 52 (NPP group))
  • Change in the physical function based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0(Baseline, Week 24 (initial group), Week 52 (NPP group))
  • Change in the Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive function(Baseline, Week 24 (initial group), Week 52 (NPP group))
  • Change in pain interference based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0(Baseline, Week 24 (initial group), Week 52 (NPP group))
  • Change in anxiety based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0(Baseline, Week 24 (initial group), Week 52 (NPP group))
  • Change in depression based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0(Baseline, Week 24 (initial group), Week 52 (NPP group))
  • Change in fatigue based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0(Baseline, Week 24 (initial group), Week 52 (NPP group))
  • Change in sleep disturbance based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0(Baseline, Week 24 (initial group), Week 52 (NPP group))
  • Change in ability to participate in social roles and activities based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0(Baseline, Week 24 (initial group), Week 52 (NPP group))
  • Change in pain interference based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0 - between baseline and 52 weeks for NPP participants(Baseline, Week 52 (T5))

Study Sites (1)

Loading locations...

Similar Trials